Japan's Parliament Backs Dovish BOJ Board Members, Raising Questions on Rate Hike Path 
Federal Reserve Crisis: DOJ Standoff Threatens Powell's Succession and Rate Stability 
Micron Technology Beats Q2 Earnings Estimates, Issues Strong AI-Driven Outlook 
DOJ Antitrust Chief Rejects Political Fast-Track for Paramount-Skydance Deal 
Paraguay Central Bank Holds Interest Rate at 5.5% Amid Slowing Growth 
Tesla Eyes $2.9 Billion in Chinese Solar Equipment to Power 100 GW U.S. Manufacturing Push 
Microsoft Eyes Legal Action as Amazon-OpenAI Deal Threatens Azure Exclusivity 
Virgin Australia Adjusts Fares Amid Rising Aviation Costs and Middle East Tensions 
J.P. Morgan Now Expects Two ECB Rate Hikes Amid Inflation Pressures 
Genel Energy Reports FY25 Net Loss Below Fears, EBITDAX Beats Forecasts 
Asian Markets Tumble as BOJ Holds Rates, Oil Surges Past $110 
HSBC Considers Cutting 20,000 Jobs Amid AI-Driven Transformation 
EA's $15B Debt Offering Draws $25B in Investor Demand Amid Credit Market Turmoil 
Asian Markets Mixed as Oil Volatility and Inflation Fears Weigh on Sentiment 
OpenAI's Desktop Superapp: Unifying ChatGPT, Codex, and Browser Tools for Enterprise AI 
U.S. Stock Futures Steady as Wall Street Retreats on Oil Volatility and Fed Rate Outlook 
China Holds Lending Rates Steady Amid Global Oil Price Surge and Middle East Tensions 
Johnson & Johnson announced it would stop selling its talc-based baby powder around the world starting next year. The New Jersey-based pharmaceutical industry company further revealed that it would be replacing the discontinued product with cornstarch-based powder.
According to CNN Business, Johnson & Johnson already halted the sale of its talc-based powder in Canada and the United States in 2020 as it has been facing thousands of lawsuits due to claims that its talcum powder caused ovarian cancer in women.
Thousands of women who have developed cancer of the ovary have sued the company. They claimed to have been using the talc-based powder regularly, and the use caused them to be afflicted with the dreaded disease.
In the lawsuits, women alleged that the asbestos in the Johnson & Johnson talcum powder causes cancer. In 2018, the jury in a St. Louis court awarded $4.7 billion to the complainants and their families. The company lost the case when the court said it was negligent and failed to warn consumers about potential health risks from the use of its baby powder.
It was noted that many other talcum powder brands had put warnings on their labels. However, Johnson & Johnson did not, and for this, it argued that such a label would be confusing. Moreover, there were scientific studies that showed an increased risk of ovarian cancer in women who use talc in their genital area, although others do not.
In any case, despite the announcement that it will no longer sell talcum powder, Johnson & Johnson still insisted that its baby powder is safe and does not cause cancer. It stated that it is still confident in the safety of the product but will be pulling them out from the market as part of a "worldwide portfolio assessment."
"We continuously evaluate and optimize our portfolio to best position the business for long-term growth," Johnson & Johnson said in a statement. "This transition will help simplify our product offerings, deliver sustainable innovation, and meet the needs of our consumers, customers and evolving global trends."
The company added, "Our position on the safety of our cosmetic talc remains unchanged and we stand firmly behind the decades of independent scientific analysis by medical experts around the world that confirms talc-based Johnson's Baby Powder is safe, does not contain asbestos, and does not cause cancer."
